Suppr超能文献

伴有框内缺失的MAP2K1及Spitz形态的黑素细胞肿瘤

Melanocytic Neoplasms With MAP2K1 in Frame Deletions and Spitz Morphology.

作者信息

Sunshine Joel C, Kim Daniel, Zhang Bin, Compres Elsy V, Khan Ayesha U, Busam Klaus J, Gerami Pedram

机构信息

Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL.

Department of Pathology, Memoral Sloan Kettering Cancer Center, New York, NY; and.

出版信息

Am J Dermatopathol. 2020 Dec;42(12):923-931. doi: 10.1097/DAD.0000000000001795.

Abstract

With the advent of better molecular characterization of Spitz melanocytic neoplasms, there has been increasing effort to better understand and describe the relationships between specific driver fusion and/or mutations with the clinical and histomorphological characteristics of the lesions. Structural rearrangements in mitogen activated protein kinase genes have recently been noted to be important in Spitz neoplasms. Only very few reports, however, have described in detail melanocytic tumors with in frame deletions in MAP2K1. Cases in the literature with this aberration have been described as having a diagnosis of Spitz, deep penetrating nevi, or pigmented epithelioid melanocytoma. In this study, we describe a cohort of 6 cases with MAP2K1 activating in frame deletions. The morphologic spectrum of the cases was broad. Common features of these cases include Spitzoid cytomorphology (5/6) cases, prominent melanin pigmentation (4/6) cases, and deep penetrating nevi-like plexiform architecture (3/6) cases. The diagnoses at the time of clinical care of these cases included nevus of Reed (1/6), desmoplastic Spitz tumor (1/6), BAPoma (1/6), deep penetrating melanocytic nevus (2/6), and melanoma (1/6). Clinical follow-up was available in 3 of the 6 cases. None of the patients had a tumor recurrence. This builds on the growing literature to help expand the spectrum of changes associated with Spitzoid melanocytic neoplasms.

摘要

随着对Spitz黑素细胞肿瘤分子特征的更好认识,人们越来越努力去更好地理解和描述特定驱动融合和/或突变与病变临床及组织形态学特征之间的关系。有丝分裂原活化蛋白激酶基因的结构重排最近被发现对Spitz肿瘤很重要。然而,只有极少数报告详细描述了具有MAP2K1框内缺失的黑素细胞肿瘤。文献中具有这种异常的病例被描述为诊断为Spitz痣、深部穿透性痣或色素性上皮样黑素细胞瘤。在本研究中,我们描述了一组6例具有MAP2K1激活框内缺失的病例。这些病例的形态学谱很广。这些病例的共同特征包括Spitz样细胞形态(5/6例)、显著的黑色素沉着(4/6例)和深部穿透性痣样丛状结构(3/6例)。这些病例临床诊治时的诊断包括Reed痣(1/6)、促纤维增生性Spitz肿瘤(1/6)、BAPoma(1/6)、深部穿透性黑素细胞痣(2/6)和黑色素瘤(1/6)。6例中有3例有临床随访资料。所有患者均无肿瘤复发。这基于不断增加的文献,有助于扩大与Spitz样黑素细胞肿瘤相关的变化谱。

相似文献

1
Melanocytic Neoplasms With MAP2K1 in Frame Deletions and Spitz Morphology.
Am J Dermatopathol. 2020 Dec;42(12):923-931. doi: 10.1097/DAD.0000000000001795.
3
Expanding spectrum of "spitzoid" lesions: a small series of 4 cases with MAP2K1 mutations.
Virchows Arch. 2021 Jul;479(1):195-202. doi: 10.1007/s00428-020-02940-3. Epub 2020 Oct 11.
4
Clinical, Morphologic, and Molecular Features of Benign and Intermediate-grade Melanocytic Tumors With Activating Mutations in MAP2K1.
Am J Surg Pathol. 2023 Dec 1;47(12):1438-1448. doi: 10.1097/PAS.0000000000002131. Epub 2023 Sep 29.
5
Spitz melanoma is a distinct subset of spitzoid melanoma.
Mod Pathol. 2020 Jun;33(6):1122-1134. doi: 10.1038/s41379-019-0445-z. Epub 2020 Jan 3.
6
Clinical and pathologic findings of Spitz nevi and atypical Spitz tumors with ALK fusions.
Am J Surg Pathol. 2014 Jul;38(7):925-33. doi: 10.1097/PAS.0000000000000187.
7
BRAF and NRAS mutations in spitzoid melanocytic lesions.
Mod Pathol. 2006 Oct;19(10):1324-32. doi: 10.1038/modpathol.3800653. Epub 2006 Jun 23.
8
Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
Hum Pathol. 2016 Dec;58:152-160. doi: 10.1016/j.humpath.2016.07.029. Epub 2016 Aug 26.
10
Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma.
Am J Surg Pathol. 2005 Sep;29(9):1145-51. doi: 10.1097/01.pas.0000157749.18591.9e.

引用本文的文献

1
Clinical outcomes and genomic profiles of MAP2K1-mutated primary cutaneous melanocytic tumours.
EBioMedicine. 2025 Apr;114:105643. doi: 10.1016/j.ebiom.2025.105643. Epub 2025 Mar 18.
2
Role of Targeted Sequencing in Routine Diagnostics of Spitz Melanocytic Neoplasms-An Analysis of 70 Cases.
J Cutan Pathol. 2025 Feb;52(2):141-153. doi: 10.1111/cup.14750. Epub 2024 Nov 7.
3
Spitz tumours and mimickers.
Virchows Arch. 2025 Jan;486(1):143-164. doi: 10.1007/s00428-024-03958-7. Epub 2024 Nov 6.
5
Spitz Melanocytic Tumors: A Fascinating 75-Year Journey.
Genes (Basel). 2024 Jan 31;15(2):195. doi: 10.3390/genes15020195.
7
Spitz Tumors and Melanoma in the Genomic Age: A Retrospective Look at Ackerman's Conundrum.
Cancers (Basel). 2023 Dec 14;15(24):5834. doi: 10.3390/cancers15245834.
8
Atypical Spitz tumor with SQSTM1::NTRK2 fusion: Report of a case with unique spindled cell features.
J Cutan Pathol. 2024 Mar;51(3):198-204. doi: 10.1111/cup.14565. Epub 2023 Nov 29.
9
The Spectrum of Spitz Melanocytic Lesions: From Morphologic Diagnosis to Molecular Classification.
Front Oncol. 2022 Jun 7;12:889223. doi: 10.3389/fonc.2022.889223. eCollection 2022.
10
The Morpho-Molecular Landscape of Spitz Neoplasms.
Int J Mol Sci. 2022 Apr 11;23(8):4211. doi: 10.3390/ijms23084211.

本文引用的文献

2
Integrating Next-Generation Sequencing with Morphology Improves Prognostic and Biologic Classification of Spitz Neoplasms.
J Invest Dermatol. 2020 Aug;140(8):1599-1608. doi: 10.1016/j.jid.2019.12.031. Epub 2020 Jan 29.
3
Melanocytic tumors with MAP3K8 fusions: report of 33 cases with morphological-genetic correlations.
Mod Pathol. 2020 May;33(5):846-857. doi: 10.1038/s41379-019-0384-8. Epub 2019 Nov 12.
6
The role of gene fusions in melanocytic neoplasms.
J Cutan Pathol. 2019 Nov;46(11):878-887. doi: 10.1111/cup.13521. Epub 2019 Jun 20.
7
Clinical validation of the tempus xT next-generation targeted oncology sequencing assay.
Oncotarget. 2019 Mar 22;10(24):2384-2396. doi: 10.18632/oncotarget.26797.
10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验